Dave James

Dave James, M.Sc. is an experienced executive in market access strategy, particularly within the virology sector. Currently serving as Executive Director of Market Access Strategy at Gilead Sciences, Dave has held significant roles including Principal Consultant at Value-Access Strategies, LLC and Executive Director at BeiGene, where responsibilities included overseeing market access value and strategy. Previous positions also include Director of U.S. Strategic & National Accounts at Intercept Pharmaceuticals and Director of Market Access Value Strategy & National Accounts at AstraZeneca, highlighting a robust background in shaping market access strategies across leading biotechnology and pharmaceutical companies.